A broad estimate for the cost per DALY averted for the three tests suggests that either the scrub typhus or CRP testing is likely to be cost-effective even at low WTP thresholds (Fig 4), despite the considerable uncertainty surrounding many model parameters. The gene discussed is CRP; the disease is scrub typhus.